ArticleBMC infectious diseases2025
Nutritional and inflammatory biomarkers for COVID-19 susceptibility: a focus on vitamin D, potassium, and hematological indices.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSince its emergence, COVID-19 has caused a global health crisis with multi-systemic complications, particularly affecting the respiratory and cardiovascular systems. Identifying potential risk factors is important for early detection of disease and may improve patients survival. This study was carried out to evaluate inflammatory, hematological and nutritional indicators to determine the risk of COVID-19 infection. MATERIALS AND
methodsThis case-control study conducted on 234 COVID-19 cases and 160 non-COVID-19 controls from 2021 to 2023 in Maragheh, northwest of Iran. Participants were recurited from referrals to local hospitals and healthcare centers of Maragheh University of Medical Sciences. Laboratory methods were employed to measure serum vitamin D, potassium, CRP, and the hematological indices. Standard statistical analysis were performed in SPSS version 21, and a p-value less than 0.05 was considered statistically significant.
resultsNo significant difference was observed in gender distribution between the two groups (54% vs. 52% female; p = 0.858). The median serum CRP level was significantly higher in COVID-19 patients (60.5 mg/L, IQR: 40.0–85.0) compared to the non-COVID-19 group (37.5 mg/L, IQR: 20.0–65.0, p < 0.001). Creatinine levels were significantly lower in the COVID-19 group (p = 0.033). Additionally, the median vitamin D level was significantly lower in the COVID-19 group (33.0 ng/mL, IQR: 22.0–45.0; p < 0.001). A significant protective effect of vitamin D, potassium, creatinine, and lymphocyte-to-CRP (Lym/CRP) ratio against COVID-19 was observed, while age, CRP, neutrophil-to-lymphocyte ratio (NLR) showed a positive association with increased risk of COVID-19 risk.
conclusionA practical clinical approach to potentially reduce the risk of COVID-19 could be assessing inflammatory (CRP and NLR) and nutritional biomarkers (vitamin D and potassium). CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.